Research On The Legal Issues Of The Supervision Of Drug Network Sales

Compared with the traditional off-line sales of pharmaceutical products,the Internet sales of pharmaceutical products rely on network technology,which has great differences in the transaction and distribution of sales.Although the Internet sales of pharmaceutical products started relatively late,but developed rapidly,at present,there are many defects in the aspects of legislation,industry norms,business order and market supervision for the Internet sales of pharmaceutical products in China,so we have to study the Internet sales of pharmaceutical products,and the regulatory problems are urgently needed to be solved under the background of current large-scale supervision.How to play the role of supervision efficiently and effectively is not only related to the healthy development of the pharmaceutical Internet sales industry,but also related to the legitimate rights and interests of drug consumers.At present,there are mainly the following regulatory problems in drug Internet sales:the main body of drug Internet sales supervision is single,mainly government departments,and the participation of industry associations is low;the internal legal responsibilities of the main body are not detailed and perfect,and the cooperation between departments is inefficient;the qualification and responsibility of Internet platform as the object of drug Internet sales supervision are insufficient;the drug Internet sales supervision The contents are complex and lack of uniform pricing regulations;consumers can not fully exercise their rights to purchase drugs through the Internet.To solve these problems,we need to make targeted analysis from the three aspects of regulatory subject,object and content in China’s current regulatory system,and on the basis of comparative analysis of the similarities and differences between domestic and foreign regulatory systems of Internet drug sales,learn from the actual experience of foreign countries in line with China,and seek solutions to the problems.In view of the regulatory subject,we need to improve laws and regulations,establish a cross regional cooperation mechanism,clarify the respective responsibilities of the drug network sales regulatory departments,and rely on government supervision and industry self-discipline,so as to effectively realize the function of the regulatory subject;in terms of the regulatory object,we need to strengthen the overall supervision of the performance of the platform obligations,engage in the pre,in and in the event After that,the whole process will be supervised to improve the construction of the compulsory regulatory system for the object of drug online sales;for the regulatory content,it is necessary to innovate the regulatory content model of drug online sales by establishing a sustained mechanism for drug information disclosure,a network pricing mechanism and a consumer protection fund.